What does DD Pharma do?

DD Pharma is a pharmacy in Leuven. Private Limited, started on 1 October 2024, 1 establishment.

What is the address of DD Pharma?

The registered office of DD Pharma is located at Tervuursesteenweg 333, 3001 Leuven.

Is DD Pharma still active?

Yes. According to the CBE (3 October 2026) DD Pharma is active, legal situation “Normale toestand”, started on 1 October 2024.

Is DD Pharma registered on Peppol?

Yes, DD Pharma is registered on the Peppol network with ID 0208:1014418872.

What is the enterprise number of DD Pharma?

The enterprise number of DD Pharma is BE1014418872.

When was DD Pharma founded?

DD Pharma was founded on 1 October 2024.

Who are the directors of DD Pharma?

According to the 2025 annual accounts, the directors of DD Pharma are: Dina Draoui.

Is DD Pharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 2024; 1 annual account filed (fiscal year 2025); 1 directors known from the annual account.

How much profit did DD Pharma make in 2025?

DD Pharma posted a profit after taxes of € 8,524 in financial year 2025.

What is the revenue of DD Pharma?

As a small company, DD Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 22,999.

DD Pharma (Private Limited) - Leuven - BE1014418872

Dossier DD Pharma, printed on 3 October 2026 from databakkes.be/en/1014418872/dd-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DD Pharma from Leuven, company number BE1014418872, closed financial year 2025 with a result of € 8,524 after tax. For that financial year DD Pharma recorded a gross margin of € 22,999 and equity of € 11,524. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Healthy

€ 11,524

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,524

Profit after tax over the fiscal year.

Cash in the bank

€ 21,199

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 8,524.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 41,888

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,366

€ 9,810 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 6,318

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,262

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to DD Pharma?

What happened at DD Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 26, 2026 New annual accounts for financial year 2025: profit of € 8,524. filed late Source: NBB ↗
Oct 1, 2024 New establishment in Leuven. KBO
Oct 1, 2024 Start of the company according to the CBE. KBO

Original PDFs at the National Bank ↗

A new publication or filing at DD Pharma? We notify you, reason included.

Follow DD Pharma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dina Draoui

DD Pharma

Behind DD Pharma is Dina Draoui.

See the full network in the app

Directors

According to the 2025 annual accounts

Dina Draoui

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Tervuursesteenweg 333

3001 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1014.418.872
VAT number: BE 1014.418.872
Registered office: Tervuursesteenweg 333, 3001 Leuven
Names & denominations: DD Pharma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 October 2024
Peppol: Active · Active since 14 Jan 2026
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗